Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B
- PMID: 24918150
- DOI: 10.5152/tjg.2014.0005
Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B
Comment on
-
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10. Gut. 2014. PMID: 24615378
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical